CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 28,515 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 71,285 shares (grant or award)
- 4 Grant or award See Remarks acquired 162,935 shares (grant or award)
- 4 Open-market sale See Remarks sold 15,853 shares at $7.64 ($121,141)
- 4 Open-market sale Chief Financial Officer sold 6,609 shares at $7.64 ($50,521)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 11 of 20 · 383 filings